- Report
- January 2023
- 166 Pages
Europe
From €3042EUR$3,450USD£2,653GBP
- Report
- January 2023
- 168 Pages
Asia Pacific
From €3042EUR$3,450USD£2,653GBP
- Report
- November 2022
- 220 Pages
Global
From €3923EUR$4,450USD£3,421GBP
- Report
- May 2022
- 240 Pages
Global
From €3923EUR$4,450USD£3,421GBP
- Report
- August 2024
- 140 Pages
Global
From €3483EUR$3,950USD£3,037GBP
- Report
- January 2024
- 146 Pages
Global
From €3747EUR$4,250USD£3,268GBP
- Report
- December 2023
- 145 Pages
Global
From €3923EUR$4,450USD£3,421GBP
- Report
- December 2023
- 148 Pages
Global
From €3923EUR$4,450USD£3,421GBP
- Report
- December 2025
- 150 Pages
Germany
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Japan
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
China
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- September 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- September 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- February 2024
- 179 Pages
Global
From €2645EUR$3,000USD£2,307GBP
- Report
- September 2023
- 115 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- July 2023
- 119 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- August 2024
- 150 Pages
Global
From €2459EUR$2,789USD£2,144GBP
- Report
- August 2024
- 200 Pages
Global
From €3411EUR$3,869USD£2,975GBP
- Report
- August 2024
- 200 Pages
Global
From €3411EUR$3,869USD£2,975GBP
- Report
- August 2024
- 150 Pages
Global
From €2459EUR$2,789USD£2,144GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more